CClinicalTrials.gg
Not yet recruitingNCT06786975SDF and ARTUpdated Dec 12, 2025

Effectiveness and Acceptability of SDF Compared to ART for the Management of Early Childhood Caries

An interventional study of Silver Diamine Fluoride and Atraumatic Restorative Treatment in Early Childhood Caries and Health Care Acceptability, sponsored by Universidad de La Frontera. Not yet recruiting at 1 site in Chile. Open to participants aged 24 Months to 71 Months. Per ClinicalTrials.gov, last updated 2025-12-12.

Sponsored by Universidad de La Frontera · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
156
Allocation
Randomized
Ages
24 Months to 71 Months
Sex
All
01

Study summary

The goal of this clinical trial is to assess the acceptability and clinical effectiveness of Silver Diamine Fluoride (SDF) in comparison with Atraumatic Restorative Treatment (ART) in Early Childhood Caries (ECC) management at the community level. The main question it aims to answer are:

  • It's SDF more accepted and effective than ART in early childhood caries management when implemented at the community level?

Participants will be diagnosed by an experienced and calibrated dentist using the International Caries Detection and Assessment System (ICDAS), then children with decayed teeth will be treated with SDF (experimental) or ART (control); another operator will choose randomly the treatment for each participant. Furthermore, oral health education component will be given to children, parents and educators.

Follow-up visits will be made at 6 and 12 months after child's treatment is complete. Before and after treatment parents will be asked to complete a child personal background survey (before), Early Childhood Oral Health Impact Scale (ECOHIS) questionnaire (before and at follow-ups) and a oral health satisfaction survey (one week after treatment and at follow-ups). The acceptability will be assessed through quantitative and qualitative methods.

Researchers will compare the SDF's groups and the ART's group to see which of them is more accepted and effective.

Read the detailed description

An open-label parallel superiority randomized clinical trial (RCT) will be conducted involving children aged 2 to 5 years.

The aim of this clinical trial is to assess the acceptability and clinical effectiveness of Silver Diamine Fluoride (SDF) in comparison with Atraumatic Restorative Treatment (ART) in Early Childhood Caries (ECC) management. As well, this clinical trial sought to compare the oral health quality of life related and to contrast possible adverse effects between both therapies.

Participants will be screened and diagnosed by an experienced and calibrated dentist using the International Caries Detection and Assessment System (ICDAS), thereafter only children with decayed teeth (or tooth) will be treated. After the diagnostic participants eligibles will be randomly chosen by another operator to be treated with SDF or ART for all teeth who need treatment in the child:

  • Experimental: SDF application in decayed teeth and oral health education component.
  • Control: ART technique in decayed teeth and oral health education component.

The oral health education component will be given to children, parents and educators.

The eligible children parents will be asked to fulfill a children personal background survey (before treatment), the Early childhood oral health impact scale (ECOHIS) questionnaire (before and after treatment at follow-ups) and a oral health satisfaction survey (a week after treatment and at follow-ups). The acceptability will be assessed through quantitative and qualitative methods.

A sample is: 234 teeth with carious lesions per group is estimated. Estimating an average of three teeth with carious lesions per child, 78 children are necessary per group.

02

Conditions studied

  • Early Childhood Caries
  • Health Care Acceptability

Keywords

  • Early Childhood Caries
  • Silver Diamine Fluoride
  • Atraumatic Restorative Treatment
03

Who can participate

Ages eligible
24 Months to 71 Months
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Children belonging to INTEGRA or JUNJI kindergarten, from 2 years up to 5 years and 11 months with informed consent signed by parents and assent from the child.
  • Children with at least one active cavitated caries lesion, extended in dentin with no signs of pulp involvement and diagnosed with ICDAS code 5.

Exclusion criteria

Exclusion Criteria:

  • Children with underlying systemic disease or disability
  • Children with known allergies to dental materials used
  • Children with transitory residence
  • Children with severe alterations of the dental estructure
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
156 participants (estimated)

Study arms

  • Experimental
    Silver Diamine Fluoride

    Participants who will receive oral health education and Silver Diamine Fluoride application in decayed teeth every 6 month. Controls will be made up to eighteen months.

    Device: Silver Diamine Fluoride

  • Active comparator
    Atraumatic Restorative Treatment

    Participants who will receive oral health education and atraumatic restorative treatment in decayed teeth. Controls will be made every 6 months up to eighteen months, in case of restoration failure it will be made again.

    Procedure: Atraumatic Restorative Treatment

Interventions

  • DeviceSilver Diamine Fluoride

    Tooth will be isolated with cotton rolls, the oral cavity will be dried with small cotton balls and the gingiva around the tooth, and surrounding structures, will be protected with vaseline. Then the silver diamine fluoride solution will be applied to cavitated caries lesions with a micro applicator for one minute approximately. If necessary the solution excess should be removed with a gauze. Finally the child's teacher will be given the indications for the child to not eat, drink or rinse up to 30 minutes after the treatment, and to evaluate if any sign or symptom related to the tooth appears.

    Also known as: Silver dental arrest, Diammine silver fluoride dental hypersensitivity varnish

  • ProcedureAtraumatic Restorative Treatment

    Participants will be treated with Atraumatic Restorative Treatment (ART) technique. Glass ionomer will be used for cavity filling (Ketac MolarTM, 3M ESPETM) according to manufacter specifications and will be applied with a spatula, followed by finger pressure using vaseline for a few seconds; for occluso-proximal cavities, a matrix band will be used. The restoration will be protected with vaseline and then the occlusion will be checked with articular paper after the initial adjustment (approximately 5 minutes). Finally the child's teacher will be given the indications for the child to not eat, drink or rinse up to 30 minutes after the treatment, and to evaluate if any sign or symptom related to the tooth appears.

05

What researchers measure

Primary outcomes

  1. Arrest of the carious lesion:

    The activity and inactivity of the lesion shall be assessed. A value of 0 shall be recorded if the lesion is inactive and a value of 1 if the lesion is active. For the assessment of activity, the parameters described in the Caries Care Guide shall be considered. For the Fluoride Diamine Silver group, the lesion's surface should have a shiny appearance and hard consistency on examination to be considered inactive, when a soft, leathery and plaque retentive tissue is present, the lesion shall be considered active. For the Atraumatic Restorative Technique group, the Caries Associated to Restoration or Sealant (CARS)\* criteria will be applied, being considered inactive if the margin is intact (good margin) and upon presentation of a restoration or plaque retentive sealant requiring adjustment or replacement will be considered active. \[\*CARS includes 3 categories: good margin; defective (plaque-retentive, can be adapted); defective(needs replacement)\]

    Time frame: 6 and 12 months

  2. Parental acceptability: quantitative measure

    Parental acceptability will be measured through a survey at 1 month, 6 months, and 12 months post-treatment following by a own elaboration questionnare.The survey includes 6 questions. Whether they would recommend the treatment based on the results (aesthetics, absence of pain, arrest of lesion) and experience of the treatment received by their child (adaptation and access to care).

    Time frame: 1 month, 6 months, and 12 months

  3. Parental acceptability: qualitative measure

    A qualitative method will be used through semi-structured interviews to be conducted one month after the intervention.Parents with the lowest (10th percentile) and highest (90th percentile) acceptability (Parental acceptability: quantitative measure) will be selected. The semi-structured interview will explore their child's experience, what factors lead them to feel satisfied/dissatisfied with the treatment, factors that influenced their child's perceived comfort or discomfort during treatment, relevance of aesthetics, importance of the care setting to their satisfaction or dissatisfaction.

    Time frame: 1 month

  4. Children's acceptability

    Children's acceptability of treatment as assessed by the operator using Frankl´s scale at the end of the initial treatment, 6 and 12 months. The minimum value=1 and the maximum value is 4. The higher scores mean a worse children's acceptability. \[Frankl´s scale was used to evaluate child's behavior in the dental setting in four categories: 1-definitely negative 2-negative 3-positive 4- definitely positive\]

    Time frame: at the end of the initial treatment, 6 and 12 months.

  5. Change in oral health-related quality of life (OHRQoL)

    Description: Change in oral health-related quality of life will be measured by the difference in the ECOHIS score between baseline and 6 months. The ECOHIS is a proxy-reported questionnaire for measuring the OHRQoL of preschool children and their families. It comprises of 13 items, covering six domains in two sections. The child's impacts section contains 4 domains. The family's impacts section contains 2 domains. Response categories for each question are rated on a 5-point Likert scale to record how often an event has occurred during the child's life: 0 = never, 1 = hardly ever, 2 = occasionally, 3 = often, 4 = very often, and 5 = don't know. ECOHIS scores are calculated as a simple sum of the response codes for the child and family sections separately and also a total score. The minimum value is 0 and maximum value is 52. Higher scores mean a worse quality of life.

    Time frame: baseline and 6 months

Secondary outcomes

  1. Absence of pulp pathology

    Absence of pulp pathology: pufa=0 Measured with pufa index\* \[\*pufa= 1 o \>1 If presents p: pulpal involvement, opening of pulp chamber is visible or coronal tooth structures are destroyed by caries u: ulceration, traumatic ulceration in the soft tissues (tongue and mucosa), caused by tooth or root fragments f: a sinus tract releasing pus originating from an abscess and opening into the oral cavity a: abscess, dento-alveolar abscess.\]

    Time frame: 6 and 12 months

  2. Presence of the tooth in the mouth.

    Presence of the tooth in the mouth. This refers to the fact that the tooth that was treated is still present in the mouth at the time of the control examination and has not been surgically extracted. It will be valued as 0 if it is present and as 1 if it has been extracted.

    Time frame: 6 and 12 months

  3. Presence of adverse effects

    A questionnaire will be applied to the parents a week after treatment and also at 6 and 12 months follow-ups after treatment, where they'll have to report the presence of any adverse effect related to treatment.

    Time frame: 6 and 12 months

06

Study locations

1 site
  • Universidad de La Frontera
    Temuco, La Araucanía 4811230, Chile
07

References and documents

Publications

  • Munoz Millan P, Pineda P, Fontana M, Freyhofer VA, Ormeno A, Munoz K, Martinez-Zapata MJ, Zaror C. Effectiveness, acceptability and oral health-related quality of life of silver diamine fluoride compared with atraumatic restorative treatment for the management of early childhood caries: protocol of a pragmatic randomised clinical trial. BMJ Open. 2026 Feb 12;16(2):e106271. doi: 10.1136/bmjopen-2025-106271. PubMed 41688106 ↗

Individual participant data

Plan to share: Yes — Data sharing plan: Study Protocol, Statistical Analysis Plan, Informed Consent Form will be available in the published protocol. The final, anonymized individual participant data (including the statistical code) that underlie the results will be available upon reasonable request. Data sharing will commence after the publication of the primary results and remain accessible for a minimum of five years. Proposals must be methodologically sound and sent to patricia.munoz@ufrontera.cl. Data users must formally sign a Data Access Agreement to ensure compliance with ethical guidelines and participant privacy. Shared data will strictly exclude any direct or indirect identifiers. All researchers using the data must agree to acknowledge the original researchers and the trial's funding source.

Supporting information: Study protocol, Sap, Icf, Analytic code

08

Registry details

Key details

Study ID
NCT06786975
Lead sponsor
Universidad de La Frontera
Responsible party
Patricia Muñoz Millán (Public Health Master, Specialist in Paediatric Dentistry, PhD exam passed at the Universidad Autónoma de Barcelona, Universidad de La Frontera) — Principal investigator
First posted
Jan 22, 2025
Start date
Dec 15, 2025 (estimated)
Primary completion
Feb 28, 2026 (estimated)
Completion
Feb 28, 2027 (estimated)
Last update
Dec 12, 2025

Study contacts

Patricia Muñoz, Master
Contact
patricia.munoz@ufrontera.cl
56452325775
Carlos Zaror, Doctor
Contact
carlos.zaror@ufrontera.cl
56452325775
Patricia Muñoz, Master
study director · Universidad de La Frontera
Patricia Pineda, Master
study chair · Universidad de La Frontera
Carlos Zaror, Doctor
study chair · Universidad de La Frontera

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion